KAIMRC through its Strategy and Business Development team, has successfully been awarded a national initiative dedicated to building and supporting clinical trials capabilities and capacities in the Kingdom of Saudi Arabia by the National Industrial Logistics Development Program (NIDLP).

KAIMRC has set up a strong foundation for the conduct and management of Clinical Trials and will continue to develop these capabilities, through this national initiative, in partnership with numerous other national biomedical and clinical research institutions as well as with key government entities and industrial partners.

This national initiative on clinical trials will allow for the long term on strengthening the pharmaceutical industry development in the Kingdom of Saudi Arabia and will pave the way for multiple options for Healthcare and drug development. Newly developed vaccines, therapeutics and medical devices will be tested in the Kingdom for the first time through rigorous clinical trials in order to test their safety and efficacy on humans.